EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · IEX Real-Time Price · USD
8.80
-0.05 (-0.56%)
At close: Jul 19, 2024, 4:00 PM
8.88
+0.08 (0.91%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
EyePoint Pharmaceuticals Market Cap
EyePoint Pharmaceuticals has a market cap or net worth of $458.34 million as of July 22, 2024. Its market cap has increased by 55.21% in one year.
Market Cap
458.34M
Enterprise Value
163.47M
1-Year Change
55.21%
Ranking
Category
Stock Price
$8.80
Market Cap Chart
Since January 27, 2005, EyePoint Pharmaceuticals's market cap has increased from $388.60M to $458.34M, an increase of 17.95%. That is a compound annual growth rate of 0.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 458.30M | -43.84% |
| Dec 29, 2023 | 816.00M | 583.99% |
| Dec 30, 2022 | 119.30M | -66.13% |
| Dec 31, 2021 | 352.20M | 273.09% |
| Dec 31, 2020 | 94.40M | -43.68% |
| Dec 31, 2019 | 167.60M | -6.53% |
| Dec 31, 2018 | 179.30M | 266.67% |
| Dec 29, 2017 | 48.90M | -16.27% |
| Dec 30, 2016 | 58.40M | -58.82% |
| Dec 31, 2015 | 141.80M | 17.58% |
| Dec 31, 2014 | 120.60M | 12.71% |
| Dec 31, 2013 | 107.00M | 279.43% |
| Dec 31, 2012 | 28.20M | 22.08% |
| Dec 30, 2011 | 23.10M | -75.61% |
| Dec 31, 2010 | 94.70M | 44.14% |
| Dec 31, 2009 | 65.70M | 281.98% |
| Dec 31, 2008 | 17.20M | -70.19% |
| Dec 31, 2007 | 57.70M | -25.93% |
| Dec 29, 2006 | 77.90M | -62.73% |
| Dec 30, 2005 | 209.00M | -46.22% |
| Jan 27, 2005 | 388.60M | - |
View and export this data all the way back to 2005.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cassava Sciences | 483.60M |
| Enhabit | 475.98M |
| Theravance Biopharma | 465.42M |
| Anavex Life Sciences | 463.84M |
| MaxCyte | 459.99M |
| Bioventus | 457.64M |
| Voyager Therapeutics | 455.27M |
| Pacific Biosciences of California | 452.11M |